New Key Statistics Module, Z-Score and F-Score
MIL:FDA Key Ratios
| Market Cap € M | 8.75 |
| Enterprise Value € M | 6.30 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.03 |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) € M | 31.00 |
| EPS (TTM) € | -3.06 |
| Beneish M-Score | -0.71 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 4.07 |
| EV-to-EBITDA | 2.40 |
| PEG | -- |
| Shares Outstanding M | 1,249.41 |
| Net Margin (%) | 3.34 |
| Operating Margin % | -2.76 |
| Pre-tax Margin (%) | 3.97 |
| Quick Ratio | 0.75 |
| Current Ratio | 1.30 |
| ROA % (ttm) | 3.87 |
| ROE % (ttm) | 20.59 |
| ROIC % (ttm) | -3.97 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.93 |
MIL:FDA Number of Guru Trades
MIL:FDA Volume of Guru Trades
Gurus Latest Trades with MIL:FDA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
MIL:FDA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers